Spreading protein across 34 meals (rather than one or two large servings) optimizes the muscle protein synthesis signal throughout the day
A trial published in the New England Journal of Medicine found that participants using tirzepatide lost up to 20.9% of their body weight over 72 weeks, with results improving progressively at higher doses across all treatment groups (Jastreboff et al., NEJM, 2022, Michigan residents across the state, from Detroit to the Upper Peninsula, have real and practical access to tirzepatide today
As part of the GLP-1 receptor agonists class, it mimics a natural hormone released after meals, assisting in weight loss and blood sugar regulation
Comparing outcomes of best-practice and research-based outpatient treatment protocols for adolescents
[1] These effects typically diminish over time as patients develop tolerance, usually within the first few weeks of therapy